Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer.
Rom J, Bechstein S, Domschke C, Golatta M, Mayer C, Heil J, Thum J, Smetanay K, Windemuth-Kieselbach C, Wallwiener M, Marme F, Schuetz F, Sohn C, Schneeweiss A.
Rom J, et al.
Anticancer Drugs. 2014 Feb;25(2):219-24. doi: 10.1097/CAD.0000000000000037.
Anticancer Drugs. 2014.
PMID: 24247203